Listen "Malaria Gets its Second Vax: Why it’s Momentous"
Episode Synopsis
A malaria vaccine developed by Oxford University and Serum Institute of India (SII) has been recommended for large-scale use by the World Health Organization (WHO). The R21/Matrix-M—only the second malaria jab—has shown up to 75% efficacy.
More episodes of the podcast Mint Primer
Trump’s murder attempt: What it means for us
15/07/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.